Category Novartis

Novartis shares fall as profit lags estimates; downside from Entresto patent loss to continue
Shares in Swiss drugmaker Novartis were seen down 3.3% in pre-market trade on Tuesday after the company reported third-quarter profitability below ...
Oct, 28, 2025
3 min read
by Invezz

Europe bulletin: UK-Turkey jet deal, market gains, and Novartis’ $12B RNA bet
European markets opened the week on a cautiously optimistic note, closing mostly higher on Monday as investors weighed key geopolitical and corpora...
Oct, 27, 2025
3 min read
by Invezz

Is it too late to buy Avidity stock after Novartis deal?
Novartis (NYSE: NVS) revealed plans of acquiring Avidity Biosciences Inc (NASDAQ: RNA) in a $12 billion all-cash transaction – valuing each share o...
Oct, 27, 2025
2 min read
by Invezz

